Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Jan Marik

Showing results (41-50 of 54) with videos related to

Pageof 6
Sort By:
Journal of Immunology (Baltimore, Md. : 1950)|May 7, 2004
Xenobiotic-induced loss of tolerance in rabbits to the mitochondrial autoantigen of primary biliary cirrhosis is reversibleKatsushi Amano, Patrick S C Leung, Qingchai Xu, et al.
Chemistry & Biology|August 2, 2011
The development of peptide-based tools for the analysis of angiogenesisAnna Fedorova, Kerry Zobel, Herman S Gill, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|May 16, 2009
PET of glial metabolism using 2-18F-fluoroacetateJan Marik, Annie Ogasawara, Baby Martin-McNulty, et al.
European Journal of Nuclear Medicine and Molecular Imaging|November 8, 2022
Development of an <sup>18</sup>F-labeled anti-human CD8 VHH for same-day immunoPET imagingShravan Kumar Sriraman, Christopher W Davies, Herman Gill, et al.
Journal of Immunology (Baltimore, Md. : 1950)|April 23, 2005
Chemical xenobiotics and mitochondrial autoantigens in primary biliary cirrhosis: identification of antibodies against a common environmental, cosmetic, and food additive, 2-octynoic acidKatsushi Amano, Patrick S C Leung, Roman Rieger, et al.
European Journal of Nuclear Medicine and Molecular Imaging|September 5, 2020
Head-to-head comparison of DFO* and DFO chelators: selection of the best candidate for clinical <sup>89</sup>Zr-immuno-PETMarion Chomet, Maxime Schreurs, Maria J Bolijn, et al.
European Journal of Nuclear Medicine and Molecular Imaging|June 30, 2019
[<sup>18</sup>F]GTP1 (Genentech Tau Probe 1), a radioligand for detecting neurofibrillary tangle tau pathology in Alzheimer's diseaseSandra Sanabria Bohórquez, Jan Marik, Annie Ogasawara, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|August 25, 2012
Immuno-PET of the hepatocyte growth factor receptor Met using the 1-armed antibody onartuzumabElaine M Jagoda, Lixin Lang, Veerendra Bhadrasetty, et al.
Oncotarget|March 31, 2016
ImmunoPET helps predicting the efficacy of antibody-drug conjugates targeting TENB2 and STEAP1Simon-Peter Williams, Annie Ogasawara, Jeff N Tinianow, et al.
Journal of Medicinal Chemistry|October 18, 2013
Enhanced tumor retention of a radiohalogen label for site-specific modification of antibodiesC Andrew Boswell, Jan Marik, Michael J Elowson, et al.
Pageof 6

Showing results (41-50 of 54) with videos related to

Sort By:
Pageof 6
Journal of Immunology (Baltimore, Md. : 1950)|May 7, 2004
Xenobiotic-induced loss of tolerance in rabbits to the mitochondrial autoantigen of primary biliary cirrhosis is reversibleKatsushi Amano, Patrick S C Leung, Qingchai Xu, et al.
Chemistry & Biology|August 2, 2011
The development of peptide-based tools for the analysis of angiogenesisAnna Fedorova, Kerry Zobel, Herman S Gill, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|May 16, 2009
PET of glial metabolism using 2-18F-fluoroacetateJan Marik, Annie Ogasawara, Baby Martin-McNulty, et al.
European Journal of Nuclear Medicine and Molecular Imaging|November 8, 2022
Development of an <sup>18</sup>F-labeled anti-human CD8 VHH for same-day immunoPET imagingShravan Kumar Sriraman, Christopher W Davies, Herman Gill, et al.
Journal of Immunology (Baltimore, Md. : 1950)|April 23, 2005
Chemical xenobiotics and mitochondrial autoantigens in primary biliary cirrhosis: identification of antibodies against a common environmental, cosmetic, and food additive, 2-octynoic acidKatsushi Amano, Patrick S C Leung, Roman Rieger, et al.
European Journal of Nuclear Medicine and Molecular Imaging|September 5, 2020
Head-to-head comparison of DFO* and DFO chelators: selection of the best candidate for clinical <sup>89</sup>Zr-immuno-PETMarion Chomet, Maxime Schreurs, Maria J Bolijn, et al.
European Journal of Nuclear Medicine and Molecular Imaging|June 30, 2019
[<sup>18</sup>F]GTP1 (Genentech Tau Probe 1), a radioligand for detecting neurofibrillary tangle tau pathology in Alzheimer's diseaseSandra Sanabria Bohórquez, Jan Marik, Annie Ogasawara, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|August 25, 2012
Immuno-PET of the hepatocyte growth factor receptor Met using the 1-armed antibody onartuzumabElaine M Jagoda, Lixin Lang, Veerendra Bhadrasetty, et al.
Oncotarget|March 31, 2016
ImmunoPET helps predicting the efficacy of antibody-drug conjugates targeting TENB2 and STEAP1Simon-Peter Williams, Annie Ogasawara, Jeff N Tinianow, et al.
Journal of Medicinal Chemistry|October 18, 2013
Enhanced tumor retention of a radiohalogen label for site-specific modification of antibodiesC Andrew Boswell, Jan Marik, Michael J Elowson, et al.
Pageof 6